NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹2,863 Cr | ₹2,657 Cr | ₹2,622 Cr | ₹2,447 Cr | ₹2,262 Cr |
What is the latest Total Non-Current Assets ratio of NATCO PHARMA ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹2,863 Cr |
Mar2023 | ₹2,657 Cr |
Mar2022 | ₹2,622 Cr |
Mar2021 | ₹2,447 Cr |
Mar2020 | ₹2,262 Cr |
How is Total Non-Current Assets of NATCO PHARMA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹2,863 Cr | 7.76 | |
Mar2023 | ₹2,657 Cr | 1.32 | |
Mar2022 | ₹2,622 Cr | 7.16 | |
Mar2021 | ₹2,447 Cr | 8.17 | |
Mar2020 | ₹2,262 Cr | - |
Compare Total Non-Current Assets of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹21,044.3 Cr | -9.8% | -15.3% | 32% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,692.0 Cr | -5.3% | -7.8% | 24.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,215.0 Cr | -3.9% | -7.9% | 51% | Stock Analytics | |
CIPLA | ₹115,000.0 Cr | -1.9% | -6.9% | 3.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,616.4 Cr | -8.3% | -14.9% | 0.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,841.4 Cr | -5.7% | -4% | 23.6% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -9.8% |
-15.3% |
32% |
SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses